M&A Deal Summary |
|
|---|---|
| Date | 2008-10-27 |
| Target | HealthMedia |
| Sector | Digital Media |
| Buyer(s) | Johnson & Johnson |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1886 |
| Sector | Consumer Products |
| Employees | 132,000 |
| Revenue | 88.8B USD (2024) |
Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 19 of 47 |
| Sector: Digital Media M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 14 of 39 |
| State: Michigan M&A | 1 of 1 |
| Country: United States M&A | 16 of 39 |
| Year: 2008 M&A | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-06-18 |
Amic AB
Uppsala, Sweden Amic is a privately held Swedish developer of in vitro diagnostic (IVD) technologies for use in Point-of-Care (POC) and near-patient settings (outside the physical facilities of the clinical laboratory). |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-01 |
Mentor
Santa Barbara, California, United States Mentor Corp. is a supplier of medical products for the global aesthetic market. The company develops, manufactures, and markets innovative, science-based products for surgical and non-surgical medical procedures that allow patients to retain a more youthful appearance and improve their quality of life. |
Buy | $1.1B |